Alloreactive natural killer cells in hematopoietic stem cell transplantation

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Allogeneic hematopoietic stem cell transplantation (HSCT) is a crucial treatment for leukemia.
• The graft-versus-leukemia (GVL) effect, mediated by donor immune cells, is key to preventing leukemia relapse post-HSCT.
• Natural killer (NK) cells and their killer-cell-immunoglobulin-like receptors (KIR) play a significant role in the GVL effect.

Purpose of the Study:

• To review the effectiveness of KIR mismatching on donor NK cells as a mechanism for GVL.
• To explore the role of KIR, T cell, and NK cell content in the graft, and graft source considerations.
• To highlight the need for further understanding of conditioning and graft-versus-host disease (GVHD) reduction to optimize NK cell manipulation in HSCT.

Main Methods:

• Literature review focusing on KIR mismatching and NK cell function in HSCT for leukemia.
• Analysis of existing data on KIR, NK cell, and T cell components of hematopoietic stem cell grafts.
• Examination of graft sources and their impact on GVL and GVHD.

Main Results:

• Mismatching inhibitory KIR on donor NK cells is an effective mechanism for inducing GVL.
• The composition of T cells and NK cells within the graft, as well as the graft source, are important factors influencing transplant outcomes.
• Understanding conditioning regimens and GVHD mitigation strategies is essential for harnessing NK cell potential.

Conclusions:

• KIR mismatching on donor NK cells represents a promising strategy to enhance GVL and reduce leukemia relapse after HSCT.
• Optimizing graft composition and source, alongside improved GVHD control, will enhance the therapeutic manipulation of NK cells in HSCT.
• Further research into conditioning and GVHD mechanisms is vital for maximizing the benefits of NK cell-mediated GVL.